Skip to main content
Subscribe
  • Sign Up Free
  • Login
  • Subscribe
  • News
    • Current News
    • Providers
    • Insurance
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • Digital Health
    • Transformation
    • ESG
    • People
    • Regional News
    • Digital Edition (Web Version)
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • Midwest
    • Northeast
    • South
    • West
  • Blogs
    • AI
    • Deals
    • Layoff Tracker
    • HIMSS 2023
  • Opinion
    • Breaking Bias
    • Commentaries
    • Letters
    • From the Editor
  • Events & Awards
    • Awards
    • Conferences
    • Galas
    • Virtual Briefings
    • Webinars
    • Nominate/Eligibility
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • Best Places to Work in Healthcare
    • Excellence in Governance
    • Health Care Hall of Fame
    • Healthcare Marketing Impact Awards
    • Top 25 Emerging Leaders
    • Top Innovators
    • Diversity in Healthcare
      • - Luminaries
      • - Top 25 Diversity Leaders
      • - Leaders to Watch
    • Women in Healthcare
      • - Luminaries
      • - Top 25 Women Leaders
      • - Women to Watch
    • Digital Health Transformation Summit
    • ESG: The Implementation Imperative Summit
    • Leadership Symposium
    • Social Determinants of Health Symposium
    • Women Leaders in Healthcare Conference
    • Best Places to Work Awards Gala
    • Health Care Hall of Fame Gala
    • Top 25 Diversity Leaders Gala
    • Top 25 Women Leaders Gala
    • - Hospital of the Future
    • - Value Based Care
    • - Hospital at Home
    • - Workplace of the Future
    • - AI and Digital Health
    • - Future of Staffing
    • - Hospital of the Future (Fall)
  • Multimedia
    • Podcast - Beyond the Byline
    • Sponsored Podcast - Healthcare Insider
    • Sponsored Video Series - One on One
    • Sponsored Video Series - Checking In with Dan Peres
  • Data & Insights
    • Data & Insights Home
    • Hospital Financials
    • Staffing & Compensation
    • Quality & Safety
    • Mergers & Acquisitions
    • Data Archive
    • Resource Guide: By the Numbers
    • Surveys
    • Data Points
  • Newsletters
  • MORE+
    • Contact Us
    • Advertise
    • Media Kit
    • Jobs
    • People on the Move
    • Reprints & Licensing
MENU
Breadcrumb
  1. Home
  2. Government
March 02, 2016 11:00 PM

Part D cost-cutting measures could weigh on insurers

Virgil Dickson
  • Tweet
  • Share
  • Share
  • Email
  • More
    Reprints Print

    As enrollment in Medicare Part D swells, the Medicare Payment Advisory Commission is suggesting a suite of cost-cutting measures, including one that would shift more risk to health plans. Another idea would be to drop coverage of some antidepressants and immunosuppressants.

    Those suggestions might not get a warm welcome on Capitol Hill, since they have a history of being panned by advocates, beneficiaries and lawmakers.

    With drug prices on the rise and more baby boomers joining Medicare each year, now is the time to find cost-saving measures for the program, Shinobu Suzuki, a principal policy analyst with MedPAC, said at the panel's meeting Thursday.

    But a proposal that could affect insurers immediately raised the eyebrows of a health plan executive on the panel.

    By law, Medicare Part D subsidizes 74.5% of the expected cost of basic drug benefits, with enrollees paying the remainder through premiums. The subsidy is made up of two components: direct monthly subsidy payments and expected individual reinsurance payments to plans.

    MedPAC proposes reducing the reinsurance subsidy from 80% to 20%, while increasing what a plan is paid upfront, and maintaining Medicare's overall 74.5% subsidy of basic benefits.

    MedPAC believes this would force plans to more diligently track their spending.

    “We certainly want more plan accountability, but is there a risk to [plan] stability,” said Dr. Craig Samitt, a MedPAC commissioner and chief clinical officer at Anthem. He said he was especially worried about how the proposal would affect smaller plans.

    Others supported the idea, believing it would increase the use of cheaper generic drugs.

    “I am a big fan of the recommendation that plans take on more risk,” said Kathy Buto, a MedPAC commissioner and independent health policy consultant in Arlington, Va. “They will have greater skin in the game.” She added that if generic drugs were used more often, it could reduce the need for reinsurance.

    Last year, more than 39 million Medicare beneficiaries were enrolled in Part D, through either a stand-alone prescription drug plan, or through a Medicare Advantage prescription drug plan. That's an increase of nearly 2 million beneficiaries since 2014 and nearly 17 million beneficiaries since 2006, when only 53% of eligible beneficiaries were enrolled in Part D plans, according to the Kaiser Family Foundation. That group now makes up 72% of all eligible Medicare beneficiaries.

    Perhaps the most controversial of MedPAC's suggestions was to limit which drugs would be a part of the so-called “protected class” (PDF) of Medicare Part D.

    Under the policy, a part D plan is required to cover all or substantially all drugs in six therapeutic classes: antiretrovirals; immunosuppressants when used to prevent organ rejection; antidepressants; antipsychotics; anticonvulsant agents; and antineoplastics.

    MedPAC suggested removing antidepressants and immunosuppressants used to prevent transplant rejection from the list. The commission argued that the move would save money without affecting medication access by moving patients to generic options.

    But the exact amount saved was unknown.

    The CMS has tried twice to make this change through rulemaking, once in 2012 and again in 2014. Stakeholders thwarted both efforts, arguing it would deny patients their medications. Members of both parties in Congress also slammed the idea.

    But during Thursday's meeting, panel members seemed supportive of the proposal.

    Jack Hoadley, a Georgetown University health policy analyst, did not believe the change would affect beneficiaries' access to drugs, especially in the case of antidepressants, where there are many generic options available.

    Others disagreed.

    “Restricting timely access to medicine jeopardizes patient health, puts patients at greater risk for poor clinical outcomes, and increases costs for patients and taxpayers,” Chuck Ingoglia, executive director of the Partnership for Part D Access, a healthcare coalition, and senior vice president for public policy at the National Council for Behavioral Health, said in a statement.

    In all, MedPAC presented 10 ideas for panel members to consider. They will vote on a modified or whittled-down list in April.

    Should the commission vote to approve any of the Part D proposals during their meeting next month, those proposals will be formally presented to Congress in MedPAC's annual June report.

    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    congress prescription drugs
    PBMs, Big Pharma face off in House hearing
    Biden COVID copy_i_i.jpg
    Biden administration asks employers to help more workers who lose Medicaid
    Most Popular
    1
    CMS tries luring providers to revamped Medicare ACOs
    2
    Oregon joins other states in setting ratios for nurse staffing
    3
    Blue Shield CA taps Amazon, Mark Cuban, CVS for new PBM model
    4
    A health innovation hub grows in Lake Nona Medical City
    5
    Hospital-at-home providers push for Medicaid coverage
    Sponsored Content
    Modern Healthcare Alert: Sign up for this breaking news email to be kept in the loop as urgent healthcare business news unfolds.
    Get Newsletters

    Sign up for enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today
    MH Magazine Cover

    MH magazine offers content that sheds light on healthcare leaders’ complex choices and touch points—from strategy, governance, leadership development and finance to operations, clinical care, and marketing.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS

    Our Mission

    Modern Healthcare empowers industry leaders to succeed by providing unbiased reporting of the news, insights, analysis and data.

    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Help Center
    • Advertise with Us
    • Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Modern Healthcare
    Copyright © 1996-2023. Crain Communications, Inc. All Rights Reserved.
    • News
      • Current News
      • Providers
      • Insurance
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • Digital Health
      • Transformation
        • Patients
        • Operations
        • Care Delivery
        • Payment
      • ESG
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition (Web Version)
    • Blogs
      • AI
      • Deals
      • Layoff Tracker
      • HIMSS 2023
    • Opinion
      • Breaking Bias
      • Commentaries
      • Letters
      • From the Editor
    • Events & Awards
      • Awards
        • Nominate/Eligibility
        • 100 Most Influential People
        • 50 Most Influential Clinical Executives
        • Best Places to Work in Healthcare
        • Excellence in Governance
        • Health Care Hall of Fame
        • Healthcare Marketing Impact Awards
        • Top 25 Emerging Leaders
        • Top Innovators
        • Diversity in Healthcare
          • - Luminaries
          • - Top 25 Diversity Leaders
          • - Leaders to Watch
        • Women in Healthcare
          • - Luminaries
          • - Top 25 Women Leaders
          • - Women to Watch
      • Conferences
        • Digital Health Transformation Summit
        • ESG: The Implementation Imperative Summit
        • Leadership Symposium
        • Social Determinants of Health Symposium
        • Women Leaders in Healthcare Conference
      • Galas
        • Best Places to Work Awards Gala
        • Health Care Hall of Fame Gala
        • Top 25 Diversity Leaders Gala
        • Top 25 Women Leaders Gala
      • Virtual Briefings
        • - Hospital of the Future
        • - Value Based Care
        • - Hospital at Home
        • - Workplace of the Future
        • - AI and Digital Health
        • - Future of Staffing
        • - Hospital of the Future (Fall)
      • Webinars
    • Multimedia
      • Podcast - Beyond the Byline
      • Sponsored Podcast - Healthcare Insider
      • Sponsored Video Series - One on One
      • Sponsored Video Series - Checking In with Dan Peres
    • Data & Insights
      • Data & Insights Home
      • Hospital Financials
      • Staffing & Compensation
      • Quality & Safety
      • Mergers & Acquisitions
      • Data Archive
      • Resource Guide: By the Numbers
      • Surveys
      • Data Points
    • Newsletters
    • MORE+
      • Contact Us
      • Advertise
      • Media Kit
      • Jobs
      • People on the Move
      • Reprints & Licensing